Background Recent nationally representative estimates from the USA suggest the prevalence of cigarette smoking continues to be much higher among those with mental disorders compared with those without; however, prevalence estimates for current cigarette use by specific diagnoses are outdated.
Methods We analysed data from the National Epidemiologic Survey on Alcohol and Related Conditions III (2012–2013). We estimated the prevalence of lifetime and past-year smoking, lifetime and past-year daily smoking, and lifetime smoking cessation among ever smokers (ie, the quit ratio) among those with common mood, anxiety and substance use disorders in comparison to those without these disorders.
Results Across disorders, smoking prevalence was higher and the quit ratio was lower among those with common mental disorders compared with those without, with twofold to sixfold relativedifferences in the odds of the magnitude.
Conclusions Despite tobacco control advances since 2000 and resulting declines in smoking prevalence, smoking remains extraordinarily more common among those with mood, anxiety and substance use disorders, with highest rates among those with bipolar and substance use disorders.
- priority/special populations
- surveillance and monitoring
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors All authors contributed to the drafting of the manuscript, and have approved of the final submission. PHS led the study’s design, execution and reporting. SAM and RDG provided conceptual oversight on the study design, execution and reporting. MC, JB and JR provided conceptual support for the study rationale, analyses and reporting of results.
Funding NIH grants P20 CA192993 (PI: PHS and Jamie Ostroff), P50 DA033945 (PI: SAM), R01 DA20892 (PI: RDG).
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.